Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE758
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,283
Award facts
- Contract value 100% obligated
- $13,283.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,283.34 to AmerisourceBergen Drug Corp on December 4, 2025, for pharmaceutical products and medical supplies under a firm fixed price contract. This non-set-aside delivery order, with an ultimate completion date of December 5, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, has demonstrated extensive capacity to fulfill military and veteran healthcare medical supply needs through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals.
This delivery order is issued under AmerisourceBergen's existing $999.999 billion IDC with DLA Troop Support Medical, designated SPE2DX and running through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to make multiple regional awards, positioning AmerisourceBergen as one of several strategic contractors supporting the federal government's extensive medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DU26FE758?
SPE2DU26FE758 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DU26FE758 worth?
The government has obligated $13,283 on SPE2DU26FE758.
Is contract SPE2DU26FE758 an order under another contract?
Yes. SPE2DU26FE758 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE758 competed?
The extent of competition for SPE2DU26FE758 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award